We decode the diseases.
Patients live the answers.
Pioneering precise therapies through cutting-edge AI technology
Redefine Clinical Development with AI
Evergreen Therapeutics is an innovative biotechnology company, leveraging AI clinical expertise to redefine drug development. We are dedicated to pioneering “First-in-Disease” precision therapies.
Bridging the Gap Between R&D and Patient Access
Globally, numerous patients continue to suffer from diseases for which there are no effective treatments
Conventional medical R&D paradigm with lengthy cycles and high failure rates often create bottlenecks. This hinders treatment access for those with complex and chronic conditions.
Addressing these health challenges is imperative and necessitates expediting the pace of therapy development to ensure patients receive tangible benefits in a more timely manner.
Pioneering Therapies for Unmet Medical Needs
Evergreen Therapeutics is committed to advancing novel drug candidates addressing critical clinical gaps. Our pipeline targets indications including Cognitive Impairment in NPSLE, Dry Age-Related Macular Degeneration (Dry-AMD), Preeclampsia, and other conditions with persistent unmet patient needs.
Explore
AI powers precise indication discovery
Our AI platform fundamentally transforms drug discovery and development. It systematically elucidates molecular mechanisms and validates therapeutic hypotheses, enabling precise target identification, deeper understanding of disease mechanisms, and optimized clinical trial design across the entire drug development lifecycle.
Explore
Expert team, patient-focused innovation.
Backed by experts from multidisciplinary backgrounds including clinical, computational, and regulatory science, our experienced management team is dedicated to delivering effective treatments to patients.
